Dataset Information

Involvement of Fathers in Pediatric Obesity Treatment and Prevention Trials: A Systematic Review.

ABSTRACT:

Context

Despite their important influence on child health, it is assumed that fathers are less likely than mothers to participate in pediatric obesity treatment and prevention research.

Objective

This review investigated the involvement of fathers in obesity treatment and prevention programs targeting children and adolescents (0-18 years).

Data sources

A systematic review of English, peer-reviewed articles across 7 databases. Retrieved records included at least 1 search term from 2 groups: "participants" (eg, child*, parent*) and "outcomes": (eg, obes*, diet*).

Study selection

Randomized controlled trials (RCTs) assessing behavioral interventions to prevent or treat obesity in pediatric samples were eligible. Parents must have "actively participated" in the study.

Data extraction

Two authors independently extracted data using a predefined template.

Results

The search retrieved 213 eligible RCTs. Of the RCTs that limited participation to 1 parent only (n = 80), fathers represented only 6% of parents. In RCTs in which participation was open to both parents (n = 133), 92% did not report objective data on father involvement. No study characteristics moderated the level of father involvement, with fathers underrepresented across all study types. Only 4 studies (2%) suggested that a lack of fathers was a possible limitation. Two studies (1%) reported explicit attempts to increase father involvement.

Limitations

The review was limited to RCTs published in English peer-reviewed journals over a 10-year period.

Conclusions

Existing pediatric obesity treatment or prevention programs with parent involvement have not engaged fathers. Innovative strategies are needed to make participation more accessible and engaging for fathers.

SUBMITTER: Morgan PJ

PROVIDER: S-EPMC6200318 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Involvement of Fathers in Pediatric Obesity Treatment and Prevention Trials: A Systematic Review.

Morgan Philip J PJ Young Myles D MD Lloyd Adam B AB Wang Monica L ML Eather Narelle N Miller Andrew A Murtagh Elaine M EM Barnes Alyce T AT Pagoto Sherry L SL

Pediatrics 20170201 2

<h4>Context</h4>Despite their important influence on child health, it is assumed that fathers are less likely than mothers to participate in pediatric obesity treatment and prevention research.<h4>Objective</h4>This review investigated the involvement of fathers in obesity treatment and prevention programs targeting children and adolescents (0-18 years).<h4>Data sources</h4>A systematic review of English, peer-reviewed articles across 7 databases. Retrieved records included at least 1 search ter ...[more]

PMID: 28130430

Similar Datasets

Project description:BackgroundClinical significance in a randomized controlled trial (RCT) can be determined using the minimal clinically important difference (MCID), which should inform the delta value used to determine sample size. The primary objective was to assess clinical significance in the pediatric oncology randomized controlled trial (RCT) treatment literature by evaluating: (1) the relationship between the treatment effect and the delta value as reported in the sample size calculation, and (2) the concordance between statistical and clinical significance. The secondary objective was to evaluate the reporting of methodological attributes related to clinical significance.MethodsRCTs of pediatric cancer treatments, where a sample size calculation with a delta value was reported or could be calculated, were systematically reviewed. MEDLINE, EMBASE, and the Cochrane Childhood Cancer Group Specialized Register through CENTRAL were searched from inception to July 2016.ResultsRCTs (77 overall; 11 and 66), representing 95 (13 and 82) randomized questions were included for non-inferiority and superiority RCTs (herein, respectively). The minority (22.1% overall; 76.9 and 13.4%) of randomized questions reported conclusions based on clinical significance, and only 4.2% (15.4 and 2.4%) explicitly based the delta value on the MCID. Over half (67.4% overall; 92.3 and 63.4%) reported a confidence interval or standard error for the primary outcome experimental and control values and 12.6% (46.2 and 7.3%) reported the treatment effect, respectively. Of the 47 randomized questions in superiority trials that reported statistically non-significant findings, 25.5% were possibly clinically significant. Of the 24 randomized questions in superiority trials that were statistically significant, only 8.3% were definitely clinically significant.ConclusionsA minority of RCTs in the pediatric oncology literature reported methodological attributes related to clinical significance and a notable portion of statistically insignificant studies were possibly clinically significance.

Dataset Information

Involvement of Fathers in Pediatric Obesity Treatment and Prevention Trials: A Systematic Review.

Context

Objective

Data sources

Study selection

Data extraction

Results

Limitations

Conclusions

Publications

Involvement of Fathers in Pediatric Obesity Treatment and Prevention Trials: A Systematic Review.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets